Email Updates

Search form

You are here

1 NOVEMBER 2019 VOLUME 20 ISSUE 42

Media Coverage

  • People at high risk of contracting HIV will be protected against the infections under the government plans to supply the risky groups with preexposure prophylaxis (PrEP) effective next month.

    October 31, 2019
    All Africa
  • The government is phasing out a common anti-HIV drug used by 15,000 children and adolescents. The discontinuation is being done gradually and by December, Nevirapine will no longer be used in Kenya. Acting Health director-general Wekesa Masasabi said the affected group will instead receive a treatment regimen of dolutegravir (DTG).

    October 31, 2019
    The Star
  • Global pharmaceutical company Sanofi has agreed to slash the price of its preventive tuberculosis medicine as part of a major deal that is expected to benefit an estimated 1.7 billion people.

    October 31, 2019
    General
    Devex
  • The Trump administration is aiming to lower new HIV infections by more than 90 percent—to 3,000 a year by 2030—but officials expect an initial bump in new diagnoses over the next two years.

    October 30, 2019
    General
    Bloomberg Law
  • Pakistan’s government suspended a pediatrician accused of reusing syringes and infecting scores of children with HIV after it was discovered that he had been reassigned to a government-run hospital, in a case that raised fury across the country.

    October 30, 2019
    General
    New York Times
  • Zimbabwe will carry out a national household based survey to assess the disease burden of HIV and evaluate impact of multi stakeholder interventions, health officials have said.

    October 30, 2019
    General
    All Africa
  • Remember when the President promised to “defeat AIDS in America” during his State of the Union address in February? Well, the Trump administration has finally explained how the hell it plans to do that, and it involves expanding access to drugs that reduce the risk of HIV transmission by as much as 99 percent, when taken as directed.

    October 30, 2019
    VICE
  • In what may be a watershed moment in the fight against tuberculosis, the world’s most lethal infectious disease, an experimental new vaccine has protected about half the people who got it, scientists reported on Tuesday.

    October 29, 2019
    General
    New York Times
  • Shortly after a unanimous vote in the UN Security Council to pass a resolution on women, peace and security, the US Mission to the UN, headed by Ambassador Kelly Craft, released a press statement criticizing references to "sexual and reproductive health."

    October 29, 2019
    General
    Newsweek
  • The Federal Trade Commission says Gilead Sciences Inc. is on the wrong side of a key issue in a Northern District of California lawsuit claiming it schemed to maintain the market “stranglehold” enjoyed by its blockbuster HIV drug Truvada.

    October 28, 2019
    Bloomberg Law
  • Californians waiting to purchase HIV prevention medication through their pharmacies will have to wait a little longer. With the signing of California Senate Bill 159 (SB 159) into law earlier this month, Governor Gavin Newsom made the state the first in the nation to allow pharmacists to sell pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to patients without a physician's prescription. Although the law will go into effect Jan.

    October 28, 2019
    The BodyPro
  • HIV-positive people who live on the streets are less likely to be successful in suppressing the virus with medication, according to a 2017 National Institute of Health study and the US Department of Health and Human Services. One reason, health experts say, is that they usually carry all their belongings with them every day, and their medicine, valued at hundreds of dollars per prescription bottle, is often lost or stolen as they navigate life on the streets.

    October 26, 2019
    Associated Press
  • HIV/AIDS has gone from a mysterious deadly illness to a manageable chronic disease. But a lot happened in the roughly four decades it took to get there. And, according to the American activist David Barr, there's much that needs to be done to ensure the gains are not reversed.

    October 23, 2019
    General
    Politico

Published Research

Announcements